233 related articles for article (PubMed ID: 20633147)
1. Biocompatibility and calcification of bovine pericardium employed for the construction of cardiac bioprostheses treated with different chemical crosslink methods.
Jorge-Herrero E; Fonseca C; Barge AP; Turnay J; Olmo N; Fernández P; Lizarbe MA; García Páez JM
Artif Organs; 2010 May; 34(5):E168-76. PubMed ID: 20633147
[TBL] [Abstract][Full Text] [Related]
2. Influence of different chemical cross-linking treatments on the properties of bovine pericardium and collagen.
Jorge-Herrero E; Fernández P; Turnay J; Olmo N; Calero P; García R; Freile I; Castillo-Olivares JL
Biomaterials; 1999 Mar; 20(6):539-45. PubMed ID: 10213357
[TBL] [Abstract][Full Text] [Related]
3. Enhanced biostability and biocompatibility of decellularized bovine pericardium, crosslinked with an ultra-low concentration monomeric aldehyde and treated with ADAPT.
Neethling WM; Yadav S; Hodge AJ; Glancy R
J Heart Valve Dis; 2008 Jul; 17(4):456-63; discussion 464. PubMed ID: 18751476
[TBL] [Abstract][Full Text] [Related]
4. Short duration gluteraldehyde cross linking of decellularized bovine pericardium improves biological response.
Umashankar PR; Arun T; Kumari TV
J Biomed Mater Res A; 2011 Jun; 97(3):311-20. PubMed ID: 21448995
[TBL] [Abstract][Full Text] [Related]
5. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
6. Biostability, durability and calcification of cryopreserved human pericardium after rapid glutaraldehyde-stabilization versus multistep ADAPT(R) treatment in a subcutaneous rat model.
Neethling W; Brizard C; Firth L; Glancy R
Eur J Cardiothorac Surg; 2014 Apr; 45(4):e110-7. PubMed ID: 24431173
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.
Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA
J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
9. In vitro properties and performance of glutaraldehyde-crosslinked bovine pericardial bioprostheses treated with glutamic acid.
Braile MC; Carnevalli NC; Goissis G; Ramirez VA; Braile DM
Artif Organs; 2011 May; 35(5):497-501. PubMed ID: 21595718
[TBL] [Abstract][Full Text] [Related]
10. Biomechanical characterization of decellularized and cross-linked bovine pericardium.
Oswal D; Korossis S; Mirsadraee S; Wilcox H; Watterson K; Fisher J; Ingham E
J Heart Valve Dis; 2007 Mar; 16(2):165-74. PubMed ID: 17484467
[TBL] [Abstract][Full Text] [Related]
11. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
12. Detoxification process for glutaraldehyde-treated bovine pericardium: biological, chemical and mechanical characterization.
Stacchino C; Bona G; Bonetti F; Rinaldi S; Della Ciana L; Grignani A
J Heart Valve Dis; 1998 Mar; 7(2):190-4. PubMed ID: 9587860
[TBL] [Abstract][Full Text] [Related]
13. Crosslinkage of collagen by polyglycidyl ethers.
Tang Z; Yue Y
ASAIO J; 1995; 41(1):72-8. PubMed ID: 7727825
[TBL] [Abstract][Full Text] [Related]
14. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
15. Histological evaluation of biocompatibility of lyophilized bovine pericardium implanted subcutaneously in rats.
Maizato MJ; Pires MD; Canzian M; Higa OZ; Pitombo RN; Leirner AA
Artif Organs; 2008 Apr; 32(4):268-71. PubMed ID: 18370939
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of calcification with citric acid in pericardial bioprosthetic heart valve material: a preliminary report.
Sucu N; Tamer L; Aytacoglu B; Polat A; Dondas HA; Gul A; Dikmengil M; Atik U
J Heart Valve Dis; 2004 Jul; 13(4):697-700. PubMed ID: 15311880
[TBL] [Abstract][Full Text] [Related]
17. Combined anticalcification treatment of bovine pericardium with decellularization and hyaluronic acid derivative.
Zhu D; Jin L; Wang X; Xu L; Liu T
Biomed Mater Eng; 2014; 24(1):741-9. PubMed ID: 24211959
[TBL] [Abstract][Full Text] [Related]
18. Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation.
Lee WK; Park KD; Kim YH; Suh H; Park JC; Lee JE; Sun K; Baek MJ; Kim HM; Kim SH
J Biomed Mater Res; 2001; 58(1):27-35. PubMed ID: 11152994
[TBL] [Abstract][Full Text] [Related]
19. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo.
Xi T; Ma J; Tian W; Lei X; Long S; Xi B
J Biomed Mater Res; 1992 Sep; 26(9):1241-51. PubMed ID: 1429769
[TBL] [Abstract][Full Text] [Related]
20. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model.
Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S
J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
